2022 Files
09:15 – 10:30 |
ORAL PRESENTATIONS OF ORIGINAL RESEARCH WORK AND OF CLINICAL CASESAt the end of this session, participants will be better able to:
|
||
“A Cross-Sectional Study of Factors Associated with Sleep Disturbance in Systemic Sclerosis: A Scleroderma Patient-centered Intervention Network (SPIN) Cohort Study”Marieke Alexandra Neyer |
|||
“Use and Perceptions of Nutrition Information Resources Among People with Systemic Sclerosis from the Scleroderma Patient-centered Intervention Network (SPIN)”Nora Østbø Mork |
|||
“Cross-Sectional Study on Factors Associated with Symptoms of Anxiety and Depresssion among People with Systemic Sclerosis: A Scleroderma Patient-centered Intervention Network (SPIN) Cohort Study”Sabrina Provencher |
|||
“Seronegative Polyarthritis in Association with Anti-NXP2 Autoantibodies: A Case Series and Literature Review”Dr. Aurélie Mourot |
|||
“Effectiveness and safety of tofacitinib in Canadian patients with rheumatoid arthritis with vs without cardiovascular risk factors: a subgroup analysis of the multicentre, observational CANTORAL study”Dr. Boulos Haraoui |
|||
10:30 – 10:45 | Pause | ||
10:45 – 11:40 |
“An ounce of prevention is worth a pound of cure: Vaccines in Rheumatology”Dre Ines Colmegna At the end of this session, participants will be better able to:
|
||
11:40 – 12:00 | Discussion | ||
12:00 – 12:15 | Remise des prix | ||
12:15 – 13:00 | Lunch | ||
13:00 – 13:55 |
“Intérêt de l’éducation thérapeutique du patient dans les maladies rhumatologiques”Dre Catherine Beauvais At the end of this session, participants will be better able to:
|
||
13:55 – 14:15 | Discussion | ||
14:15 – 14:30 | Pause | ||
14:30 – 15:25 |
“Insights from the Hopkins Lupus Cohort”Dre Michelle Petri At the end of this session, participants will be better able to:
|
||
15:25 – 15:45 | Discussion | ||
15:45 – 16:00 | Mots de clôture | ||
16h00 | End of the Conference |
2021 Files
09:00 – 09:15 | Welcoming Remarks
Moderator: Dr Carol Yeadon |
||
09:15 – 10:30 |
ORAL PRESENTATIONS OF ORIGINAL RESEARCH WORK AND OF CLINICAL CASESAt the end of this session, participants will be better able to:
|
||
“Stressful Life Events in the Year Prior to RA Diagnosis Affect RA Disease Characteristics at Baseline and 1 Year: Results from the Canadian Early Arthritis Cohort (CATCH)”Nicole Andersen |
|||
“Associations among fatigue, vitality, sleep, and health-related quality of life in patients with rheumatoid arthritis: Data from Phase 3 trials of tofacitinib”Dre Susan Bartlett |
|||
“Prediction Tool for Damage Accrual Trajectory in Incident Systemic Sclerosis”Dre Ariane Barbacki |
|||
“Patient Preferences for Hydroxychloroquine in Systemic Lupus: Preliminary Analyses”Dre Celline Brasil |
|||
“Scleromyositis is Associated with Distinct Muscle Vasculopathic Features”Dre Océane Landon-Cardinal |
|||
10:30 – 10:45 | BREAK | ||
10:45 – 11:40 |
“ADVANCES IN THE PATHOGENESIS OF SPONDYLOARTHRITISDr Robert D Inman At the end of this session, participants will be better able to:
|
||
11:40 – 12:00 | Discussion | ||
12:00 – 12:15 | AWARDS PRESENTATION | ||
12:15 – 13:00 | Lunch | ||
13:00 – 13:55 |
“LA MALADIE DE PAGET EST-ELLE DEVENUE UNE MALADIE OSSEUSE RARE?”Dr Laëtitia Michou At the end of this session, participants will be better able to:
|
||
13:55 – 14:15 | Discussion | ||
14:15 – 14:30 | Break | ||
14:30 – 15:25 |
“IgG4 RELATED DISEASES”Dr Hughes Allard-Chamard At the end of this session, participants will be better able to:
|
||
15:25 – 15:45 | Discussion | ||
15:45 – 16:00 | Closing Remarks | ||
16h00 | End of the Conference |